Literature DB >> 15842971

Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.

Robert H Schneider1, Charles N Alexander, Frank Staggers, Maxwell Rainforth, John W Salerno, Arthur Hartz, Stephen Arndt, Vernon A Barnes, Sanford I Nidich.   

Abstract

Psychosocial stress contributes to high blood pressure and subsequent cardiovascular morbidity and mortality. Previous controlled studies have associated decreasing stress with the Transcendental Meditation (TM) program with lower blood pressure. The objective of the present study was to evaluate, over the long term, all-cause and cause-specific mortality in older subjects who had high blood pressure and who participated in randomized controlled trials that included the TM program and other behavioral stress-decreasing interventions. Patient data were pooled from 2 published randomized controlled trials that compared TM, other behavioral interventions, and usual therapy for high blood pressure. There were 202 subjects, including 77 whites (mean age 81 years) and 125 African-American (mean age 66 years) men and women. In these studies, average baseline blood pressure was in the prehypertensive or stage I hypertension range. Follow-up of vital status and cause of death over a maximum of 18.8 years was determined from the National Death Index. Survival analysis was used to compare intervention groups on mortality rates after adjusting for study location. Mean follow-up was 7.6 +/- 3.5 years. Compared with combined controls, the TM group showed a 23% decrease in the primary outcome of all-cause mortality after maximum follow-up (relative risk 0.77, p = 0.039). Secondary analyses showed a 30% decrease in the rate of cardiovascular mortality (relative risk 0.70, p = 0.045) and a 49% decrease in the rate of mortality due to cancer (relative risk 0.49, p = 0.16) in the TM group compared with combined controls. These results suggest that a specific stress-decreasing approach used in the prevention and control of high blood pressure, such as the TM program, may contribute to decreased mortality from all causes and cardiovascular disease in older subjects who have systemic hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15842971      PMCID: PMC1482831          DOI: 10.1016/j.amjcard.2004.12.058

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  The physiology of meditation: a review. A wakeful hypometabolic integrated response.

Authors:  R Jevning; R K Wallace; M Beidebach
Journal:  Neurosci Biobehav Rev       Date:  1992       Impact factor: 8.989

2.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

3.  Calcium-channel blockers for hypertension--uncertainty continues.

Authors:  J A Cutler
Journal:  N Engl J Med       Date:  1998-03-05       Impact factor: 91.245

4.  Psychotherapeutic effects of transcendental meditation with controls for expectation of relief and daily sitting.

Authors:  J C Smith
Journal:  J Consult Clin Psychol       Date:  1976-08

5.  Comparability of mortality follow-up before and after the National Death Index.

Authors:  S A Edlavitch; J Baxter
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897

6.  Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly.

Authors:  C N Alexander; E J Langer; R I Newman; H M Chandler; J L Davies
Journal:  J Pers Soc Psychol       Date:  1989-12

7.  Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group.

Authors:  L A Stewart; M J Clarke
Journal:  Stat Med       Date:  1995-10-15       Impact factor: 2.373

Review 8.  Cognitive behavioral techniques for hypertension: are they effective?

Authors:  D M Eisenberg; T L Delbanco; C S Berkey; T J Kaptchuk; B Kupelnick; J Kuhl; T C Chalmers
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

9.  Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis.

Authors:  C N Alexander; R H Schneider; F Staggers; W Sheppard; B M Clayborne; M Rainforth; J Salerno; K Kondwani; S Smith; K G Walton; B Egan
Journal:  Hypertension       Date:  1996-08       Impact factor: 10.190

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more
  42 in total

1.  Effects of spiritual mantram repetition on HIV outcomes: a randomized controlled trial.

Authors:  Jill E Bormann; Allen L Gifford; Martha Shively; Tom L Smith; Laura Redwine; Ann Kelly; Sheryl Becker; Madeline Gershwin; Patricia Bone; Wendy Belding
Journal:  J Behav Med       Date:  2006-07-18

2.  Evidence-based common sense?

Authors:  Mark Sherman
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

3.  Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study.

Authors:  Ravishankar Jayadevappa; Jerry C Johnson; Bernard S Bloom; Sanford Nidich; Shashank Desai; Sumedha Chhatre; Donna B Raziano; Robert Schneider
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

4.  Mindfulness-Based Stress Reduction and Group Support Decrease Stress in Adolescents with Cardiac Diagnoses: A Randomized Two-Group Study.

Authors:  Vicki A Freedenberg; Pamela S Hinds; Erika Friedmann
Journal:  Pediatr Cardiol       Date:  2017-07-12       Impact factor: 1.655

Review 5.  Meditation and coronary heart disease: a review of the current clinical evidence.

Authors:  Indranill Basu Ray; Arthur R Menezes; Pavan Malur; Aimee E Hiltbold; John P Reilly; Carl J Lavie
Journal:  Ochsner J       Date:  2014

6.  Tension Tamer: delivering meditation with objective heart rate acquisition for adherence monitoring using a smart phone platform.

Authors:  Mathew J Gregoski; Alexey Vertegel; Aleksey Shaporev; Frank A Treiber
Journal:  J Altern Complement Med       Date:  2012-09-11       Impact factor: 2.579

7.  Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2006-08-01

8.  Effect of transcendental meditation on employee stress, depression, and burnout: a randomized controlled study.

Authors:  Charles Elder; Sanford Nidich; Francis Moriarty; Randi Nidich
Journal:  Perm J       Date:  2014

Review 9.  Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care.

Authors:  Robert H Schneider; Kenneth G Walton; John W Salerno; Sanford I Nidich
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

Review 10.  Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis.

Authors:  Maxwell V Rainforth; Robert H Schneider; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; James W Anderson
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.